European Journal of Nuclear Medicine and Molecular Imaging
The European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is a peer-reviewed medical journal published by Springer. It is the official journal of the European Association of Nuclear Medicine.[1] It covers the field of nuclear medicine, including dosimetry, radiation biology, radiochemistry, radiopharmacology, molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression, and antisense methodologies. According to the Journal Citation Reports, the journal has a 2016 impact factor of 7.277.[2]
 | |
| Discipline | Nuclear Medicine |
|---|---|
| Language | English |
| Edited by | Ignasi Carrio |
| Publication details | |
| History | 1976-present |
| Publisher | |
| Frequency | Monthly |
| 7.277 (2016) | |
| Standard abbreviations | |
| ISO 4 | Eur. J. Nucl. Med. Mol. Imaging |
| Indexing | |
| CODEN | EJNMA6 |
| ISSN | 1619-7070 (print) 1619-7089 (web) |
| LCCN | 2002252212 |
| OCLC no. | 49348061 |
| Links | |
Spin off
In summer of 2011, Springer launched EJNMMI Research, a peer-reviewed open access journal, as a companion to the EJNMMI. It accommodates articles that could not be published in EJNMMI.
References
- "European Association of Nuclear Medicine - EJNMMI". Eanm.org. Archived from the original on 2012-10-24. Retrieved 2012-11-01.
- "European Journal of Nuclear Medicine and Molecular Imaging". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.